Brief: Ultimovacs Q1 Operating Loss Narrows To NOK 31.2 Million
11/05/2021 07:21
May 11 (Reuters) - Ultimovacs ASA ULTIMO.OL :
* Q1 OPERATING LOSS NOK 31.2 MILLION VERSUS LOSS NOK 31.3
MILLION
YEAR AGO
Source text for Eikon: ID:nObirKWf4a
Further company coverage: ULTIMO.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Zelluna ASA
See all newsNorway's Zelluna ASA reports Q2 loss
Brief: Zelluna Reports Q2 Total Loss Of NOK 19.7 Million
Brief: Zelluna Says IDMC Recommends Recruitment Of Next Two Patients At First Dose Level
Brief: Zelluna Says First Patient Dosed With Zi-Ma4-1 In Zima-101 Phase 1 Trial
Brief: Zelluna Wins NOK 16 Mln Research Council Of Norway Grant